LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion
Using resting-state fMRI with retinotopic localisers, the study found that LSD increases functional connectivity between retinotopically congruent patches of early visual cortex (V1–V3) during eyes-closed rest compared with placebo. This suggests that under LSD the early visual system behaves as if receiving spatially localised visual input, consistent with eyes‑closed psychedelic imagery.
Authors
- Robin Carhart-Harris
- David Nutt
- Leor Roseman
Published
Abstract
The question of how spatially organized activity in the visual cortex behaves during eyes‐closed, lysergic acid diethylamide (LSD)‐induced “psychedelic imagery” (e.g., visions of geometric patterns and more complex phenomena) has never been empirically addressed, although it has been proposed that under psychedelics, with eyes‐closed, the brain may function “as if” there is visual input when there is none. In this work, resting‐state functional connectivity (RSFC) data was analyzed from 10 healthy subjects under the influence of LSD and, separately, placebo. It was suspected that eyes‐closed psychedelic imagery might involve transient local retinotopic activation, of the sort typically associated with visual stimulation. To test this, it was hypothesized that, under LSD, patches of the visual cortex with congruent retinotopic representations would show greater RSFC than incongruent patches. Using a retinotopic localizer performed during a nondrug baseline condition, nonadjacent patches of V1 and V3 that represent the vertical or the horizontal meridians of the visual field were identified. Subsequently, RSFC between V1 and V3 was measured with respect to these a priori identified patches. Consistent with our prior hypothesis, the difference between RSFC of patches with congruent retinotopic specificity (horizontal–horizontal and vertical–vertical) and those with incongruent specificity (horizontal–vertical and vertical–horizontal) increased significantly under LSD relative to placebo, suggesting that activity within the visual cortex becomes more dependent on its intrinsic retinotopic organization in the drug condition. This result may indicate that under LSD, with eyes‐closed, the early visual system behaves as if it were seeing spatially localized visual inputs. Hum Brain Mapp 37:3031–3040, 2016. © 2016 Wiley Periodicals, Inc.
Research Summary of 'LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion'
Introduction
Psychedelic effects of lysergic acid diethylamide (LSD) have been linked to activation of the serotonin 2A receptor (5-HT2A R), which is highly expressed in occipital cortex, particularly primary visual cortex (V1). Earlier work has reported occipital alpha suppression, increased blood oxygen level dependent (BOLD) signal and cerebral blood flow (CBF) in visual areas, and associations between these physiological changes and reports of visual hallucinations under psychedelics. Models of psychedelic geometric imagery have hypothesised aberrant dynamics within the retinotopically organised visual cortex, but the behaviour of spatially organised (retinotopic) spontaneous activity during eyes-closed LSD-induced imagery had not been directly tested. This study set out to test whether eyes-closed LSD alters resting-state functional connectivity (RSFC) within early visual cortex in a manner consistent with retinotopic organisation. Specifically, Roseman and colleagues hypothesised that, under LSD but not placebo, RSFC between V1 and V3 patches that represent the same polar meridian (horizontal–horizontal or vertical–vertical, i.e. retinotopically congruent) would be stronger than RSFC between patches representing different meridians (horizontal–vertical or vertical–horizontal, i.e. incongruent). The prediction reflects the idea that the early visual system under LSD may behave “as if” it were processing spatially localised visual input even with the eyes closed.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Roseman, L., Sereno, M. I., Leech, R., Kaelen, M., Orban, C., McGonigle, J., Feilding, A., Nutt, D. J., & Carhart‐Harris, R. L. (2016). LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion. Human Brain Mapping, 37(8), 3031-3040. https://doi.org/10.1002/hbm.23224
References (10)
Papers cited by this study that are also in Blossom
Alonso, J. N., Romero, S., Mañanas, M. A. et al. · International Journal of Neuropsychopharmacology (2015)
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
Carhart-Harris, R. L., Leech, R., Williams, T. M. et al. · British Journal of Psychiatry (2018)
De Araujo, D. B., Ribeiro, S., Cecchi, G. A. et al. · Human Brain Mapping (2011)
Halberstadt, A. L. · Behavioural Brain Research (2014)
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J. et al. · Journal of Neuroscience (2013)
Riba, J., Anderer, P., Jané, F. et al. · Neuropsychobiology (2004)
Schenberg, E. E., Alexandre, J. F. M., Filev, R. et al. · PLOS ONE (2015)
Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)
Valle, M., Maqueda, A. E., Rabella, M. et al. · European Neuropsychopharmacology (2016)
Cited By (28)
Papers in Blossom that reference this study
Suay, D., Aicher, H. D., Kometer, M. et al. · NeuroImage (2025)
Ertl, N., Ashraf, I., Azizi, L. et al. · Biorxiv (2025)
Stoliker, D., Preller, K. H., Novelli, L. et al. · Molecular Psychiatry (2024)
Shinozuka, K., Tewarie, P. K. B., Luppi, A. et al. · Biorxiv (2024)
Tipado, Z., Kuypers, K. P. C., Sorger, B. et al. · European Neuropsychopharmacology (2024)
Rieser, N. M., Gubser, L. P., Moujaes, F. et al. · Scientific Reports (2023)
Barnett, B. S., Sweat, N. W., Hendricks, P. S. · Drug Science Policy and Law (2023)
Bedford, P., Hauke, D. J., Wang, Z. et al. · Neuropsychopharmacology (2022)
Kwan, A. C., Olson, D. E., Preller, K. H. et al. · Nature Medicine (2022)
Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)
Show all 28 papersShow fewer
McCulloch, D. E-W., Knudsen, G. M., Barrett, F. S. et al. · Neuroscience and Biobehavioral Reviews (2022)
Barrett, F. S., Zhou, Y., Carbonaro, T. M. et al. · Frontiers in Neuroergonomics (2022)
Varley, T. F., Carhart-Harris, R., Roseman, L. et al. · NeuroImage (2020)
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Barrett, F. S., Krimmel, S. R., Griffiths, R. R. et al. · NeuroImage (2020)
Girn, M., Roseman, L., Bernhardt, B. et al. · Biorxiv (2020)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Swanson, L. R. · Frontiers in Pharmacology (2018)
Nichols, D. E. · ACS Chemical Neuroscience (2018)
Sanz, C., Zamberlan, F., Erowid, E. et al. · Frontiers in Neuroscience (2018)
Lyons, T., Carhart-Harris, R. L. · Journal of Psychopharmacology (2018)
Carbonaro, T. M., Hurwitz, E., Johnson, M. W. · Psychopharmacology (2017)
Kaelen, M., Lorenz, R., Barrett, F. S. et al. · Biorxiv (2017)
Liechti, M. E. · Neuropsychopharmacology (2017)
Kraehenmann, R. ;., Pokorny, D. ;., Vollenweider, L. ;. et al. · Psychopharmacology (2017)
Kaelen, M. · Imperial College London (2017)
Dolder, P. C., Schmid, Y., Steuer, A. E. et al. · Clinical Pharmacokinetics (2017)
Kapócs, G., Scholkmann, F., Salari, V. et al. · Reviews In The Neuroscience (2016)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.